Skip to main content

and
  1. Article

    Open Access

    Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses

    Olfactory neuroblastoma is a rare malignancy of the anterior skull base typically treated with surgery and adjuvant radiation. Although outcomes are fair for low-grade disease, patients with high-grade, recurr...

    Riley M. Larkin, Diana C. Lopez, Yvette L. Robbins in Journal of Translational Medicine (2024)